Obesity is a global health problem that affects all age groups in both developing and
developed countries. In recent years, the prevalence of overweight and obesity has reached …

Drug-induced liver injury (DILI) remains an important, yet challenging diagnosis for
physicians. Each year, additional drugs are implicated in DILI and this year was no different …

Fecal microbial transplantation (FMT) from lean donors to patients with obesity has been
associated with metabolic benefits, yet results so far have been inconsistent. In this study …

Background Visceral and ectopic fat are key drivers of adverse cardiometabolic outcomes in
obesity. We aimed to evaluate the effects of injectable liraglutide 3· 0 mg daily on body fat …

Human serum albumin, the primary transport and reservoir protein in the human circulatory
system, interacts with numerous endogenous and exogenous ligands of varying structural …

We are currently facing an obesity pandemic, with worldwide obesity rates having tripled
since 1975. Obesity is one of the main risk factors for the development of non-communicable …

Several pharmacological approaches to controlling body weight have been developed over
the last decades, albeit with limited success. Currently available agents include centrally …

This communication provides a contemporary classification of glucagon-like peptide 1
receptor agonists (GLP1RAs) based on indication, route, and frequency of administration …

Background Obesity is a complex disease with an increasing prevalence worldwide. There
are different weight-management options for obesity treatment, including dietary control …

Background: Slimming products represent a dynamically growing group of food
supplements worldwide. The efficacy of safely usable natural ingredients is usually below …